Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
704
-
Total 13F shares, excl. options
-
78.4M
-
Shares change
-
+7.22M
-
Total reported value, excl. options
-
$7.05B
-
Value change
-
+$613M
-
Put/Call ratio
-
1
-
Number of buys
-
343
-
Number of sells
-
-291
-
Price
-
$89.88
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q1 2022
897 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q1 2022.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 704 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.4M shares
.
Largest 10 shareholders include MORGAN STANLEY (9.97M shares), BANK OF AMERICA CORP /DE/ (6.11M shares), GOLDMAN SACHS GROUP INC (5.7M shares), BNP PARIBAS ARBITRAGE, SA (4.39M shares), CITIGROUP INC (4.04M shares), TORONTO DOMINION BANK (3.09M shares), Avoro Capital Advisors LLC (3.05M shares), Matrix Capital Management Company, LP (2.1M shares), UBS Group AG (2.09M shares), and Clal Insurance Enterprises Holdings Ltd (2.03M shares).
This table shows the top 704 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.